The Food and Drug Administration (FDA) has approved Calquence ® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell ...

Researchers aimed to determine the relationship between tetrahydrocannabinol positivity and epilepsy monitoring unit length of stay.

Number of U.S. adults who will develop dementia each year projected to increase from ~514,000 to 1 million; lifetime risk is 42 percent after 55 years of age ...

Researchers evaluated postoperative pain outcomes and rates of surgical intervention following no-scalpel vasectomy.

Clinical obesity defined as chronic illness resulting from effect of excess adiposity on organ and tissue function ...

After a nurse practitioner was acquitted of illegally prescribing controlled substances, she sues the United States Government and the Drug Enforcement Administration (DEA) Diversion Investigator. The ...

Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines. HealthDay News — The Advisory Committee on Immunization Practices ...

The difference in patient care experience between private equity-acquired and control hospitals increased over time and was largest in postacquisition year 3. Patient-reported care experiences ...

Mirikizumab-treated patients achieved statistically significant clinical remission and endoscopic response compared with placebo at week 52. The Food and Drug Administration (FDA) has approved ...

Public water systems with detectable levels of contaminants serve counties with higher proportions of Hispanic residents. HealthDay News — More than 97 million US residents are served by public ...

Since the early 2000s, CRC mortality has significantly decreased, largely due to advancements in screening and the removal of precancerous polyps. However, CRC continues to be the second most ...